MedTrace Logo

A Study For Using Radiosurgery On Limited Metastases

NCT00178399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2018-10-11

Study results available
· View outcomes & findings →

Summary

The standard therapy in cases such as yours is surgery, radiation therapy, chemotherapy or hormonal therapy alone or in combination. The main purpose of this study is to evaluate whether radiosurgery alone affects your quality and length of life. A second purpose of this study is to determine if the levels of special types of protein (called cytokines) found in the blood are related to your quality of life during your course of treatment and follow-up.

Conditions

  • Neoplasms, Metastatic

Interventions

PROCEDURE

Stereotactic Body Radiation Therapy

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Michael Milano, MD PhD · University of Rochester

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2007-03-15
Completion
2007-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178399 on ClinicalTrials.gov